Angelina F.
- Country
- Italy
- Department
- SC Medicina Nucleare
Research Overview
- Phase I Evaluation of [177Lu]Lu-FF58 in Patients with Recurrent Glioblastoma Multiforme, Advanced Pancreatic Ductal Adenocarcinoma, and Gastroesophageal Adenocarcinoma
- Efficacy and Safety Evaluation of Lutetium (177Lu) Oxodotreotide in Advanced GEP-NETs with High Proliferation: A Phase III Randomized Study
- Phase I/II Open-Label Multi-Center Trial of Lutetium (177Lu)-NeoBomb1 and Capecitabine in GRPR+, ER+, HER2- Metastatic Breast Cancer Post-Endocrine Therapy
Data & Insights
Has run more than one trial at 23 of 56 partner sites.
Specializations
Oncology Focus
The investigator specializes in treating advanced solid tumors with particular emphasis on neuroendocrine tumors and breast cancer. Their expertise extends to innovative therapeutic approaches for patients with both localized and metastatic disease.
- Breast Cancer Management
- Neuroendocrine Tumor Treatment
- Gastrointestinal Cancer Therapy
Specialized Treatments
The investigator's work centers on radioligand therapy applications, particularly in treating neuroendocrine prostate cancer and GEP-NETs. Their therapeutic approach includes combinations with established treatments to enhance patient outcomes.
- Targeted Radioligand Therapy
- Combination Treatment Strategies
- Advanced Cancer Care
Disease Expertise
The investigator focuses on treating multiple cancer types including pancreatic ductal adenocarcinoma, lung cancer, and glioblastoma multiforme. Their work encompasses both early-stage and advanced disease management.
- Neuroendocrine Tumors
- Gastrointestinal Cancers
- Brain Tumors
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.